EP0711310A4 - Human antibodies against varicella-zoster virus - Google Patents

Human antibodies against varicella-zoster virus

Info

Publication number
EP0711310A4
EP0711310A4 EP94922669A EP94922669A EP0711310A4 EP 0711310 A4 EP0711310 A4 EP 0711310A4 EP 94922669 A EP94922669 A EP 94922669A EP 94922669 A EP94922669 A EP 94922669A EP 0711310 A4 EP0711310 A4 EP 0711310A4
Authority
EP
European Patent Office
Prior art keywords
human antibodies
antibodies against
zoster virus
against varicella
varicella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94922669A
Other languages
German (de)
French (fr)
Other versions
EP0711310A1 (en
Inventor
Philip Lake
Lars Ostberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharmaceuticals Corp
Original Assignee
Sandoz Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Pharmaceuticals Corp filed Critical Sandoz Pharmaceuticals Corp
Publication of EP0711310A1 publication Critical patent/EP0711310A1/en
Publication of EP0711310A4 publication Critical patent/EP0711310A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C07K16/088—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP94922669A 1993-07-28 1994-07-22 Human antibodies against varicella-zoster virus Withdrawn EP0711310A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US9847993A 1993-07-28 1993-07-28
US08/217,918 US5506132A (en) 1993-07-28 1994-03-24 Human antibodies against varicella-zoster virus
PCT/US1994/008241 WO1995004080A1 (en) 1993-07-28 1994-07-22 Human antibodies against varicella-zoster virus
US98479 1998-06-16
US217918 1998-12-21

Publications (2)

Publication Number Publication Date
EP0711310A1 EP0711310A1 (en) 1996-05-15
EP0711310A4 true EP0711310A4 (en) 1998-08-05

Family

ID=26794782

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94922669A Withdrawn EP0711310A4 (en) 1993-07-28 1994-07-22 Human antibodies against varicella-zoster virus

Country Status (6)

Country Link
US (1) US5506132A (en)
EP (1) EP0711310A4 (en)
JP (1) JPH09501050A (en)
AU (1) AU690916B2 (en)
CA (1) CA2168230A1 (en)
WO (1) WO1995004080A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100434023B1 (en) * 1996-02-29 2005-05-09 주식회사 엘지생명과학 Animal cell line expressing glycoprotein of varicella-zoster virus
US5710248A (en) * 1996-07-29 1998-01-20 University Of Iowa Research Foundation Peptide tag for immunodetection and immunopurification
DK0966533T3 (en) 1997-02-07 2010-01-04 Us Gov Health & Human Serv Activity-dependent neurotrophic factor III (ADNF III).
US6197582B1 (en) * 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
US7060802B1 (en) * 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
CA2492883C (en) 2002-08-01 2012-10-02 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
CN101146554B (en) 2005-01-27 2012-10-10 加州大学评议会 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
KR101154276B1 (en) * 2006-11-17 2012-07-10 사이단호진한다이비세이부쯔뵤우겐큐우카이 Nerve elongation promoter and elongation inhibitor
JP2010517557A (en) * 2007-02-06 2010-05-27 リボバックス バイオテクノロジーズ ソシエテ アノニム Antibodies specific for varicella-zoster virus
US10066019B2 (en) 2012-10-12 2018-09-04 Agency For Science, Technology And Research Optimised heavy chain and light chain signal peptides for the production of recombinant antibody therapeutics
US11147870B2 (en) * 2018-04-25 2021-10-19 Emory University Specific binding agents to varicella-zoster virus and uses related thereto
CN112386688B (en) * 2021-01-20 2021-09-24 广东新征程生命科学有限公司 A pharmaceutical composition containing immunocyte for treating virus
CN114933649B (en) * 2021-03-10 2023-04-21 北京智仁美博生物科技有限公司 Antibodies against varicella-zoster virus and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2060509C (en) * 1990-04-20 1996-07-23 Yasuhiko Masuho Human monoclonal antibody to glycoprotein gpiii of varicella zoster virus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
AU690916B2 (en) 1998-05-07
CA2168230A1 (en) 1995-02-09
AU7370094A (en) 1995-02-28
EP0711310A1 (en) 1996-05-15
WO1995004080A1 (en) 1995-02-09
US5506132A (en) 1996-04-09
JPH09501050A (en) 1997-02-04

Similar Documents

Publication Publication Date Title
HU9601574D0 (en) Humanized antibodies and uses thereof
ZA959336B (en) Antibodies
IL122589A0 (en) Vaccines against hepatitis c
ZA947828B (en) Vaccines
GB9412166D0 (en) Retargetting antibodies
EP0711310A4 (en) Human antibodies against varicella-zoster virus
GB9325496D0 (en) Vaccines
GB9304658D0 (en) Flatus filters
ZA948685B (en) Vaccines
ZA948729B (en) Vaccines
GB9223676D0 (en) Modified antibodies
GB9526433D0 (en) Vaccine component
GB9213362D0 (en) Hcv-3 virus
GB9508704D0 (en) Virus
GB9320508D0 (en) Antibodies
GB9309884D0 (en) Antibodies
GB9420956D0 (en) Virus
GB9421007D0 (en) Virus
GB9222573D0 (en) Antibodies
GB9207192D0 (en) Antibodies
GB9312415D0 (en) Altered antibodies
GB9526438D0 (en) Vaccine component
GB9207360D0 (en) Antigen preparation
GB9509425D0 (en) "Virus"
GB9306398D0 (en) Vaccines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RHK1 Main classification (correction)

Ipc: C12N 5/22

A4 Supplementary search report drawn up and despatched

Effective date: 19980622

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000706

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020226